The Histone Deacetylase Inhibitor Trichostatin A Has Genotoxic Effects in Human Lymphoblasts In Vitro
Authors:
Open Access
- 20 July 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 93 (2) , 341-347
Abstract
Histone deacetylase inhibitors (HDACi) are a class of putative chemotherapeutic agents for which the mechanism of toxicity has not been fully identified. To explore the possibility that HDACi are genotoxic, human TK6 lymphoblastoid cells were exposed to trichostatin A (TSA) and genetic damage was measured. TSA caused a dose-dependent increase of G1-arrested cells at 24 h that correlated with increasing levels of p21 and apoptosis. Significantly elevated frequencies of structural chromosomal aberrations in cells exposed to TSA were observed using both the kinetochore-antibody micronucleus assay and nonbanding metaphase chromosome analysis. Increased tail intensities, indicative of elevated levels of DNA damage, were observed using the alkaline comet assay. Elevated levels of phosphorylated histone γH2AX protein were observed as early as 3 h following TSA exposure and peaked at 12 h for 200nM TSA. Significant levels of aneuploidy at the 200nM TSA dose were observed using metaphase analysis, but interestingly, kinetochore-positive micronuclei were not detected at any dose using the kinetochore micronucleus assay, suggesting that TSA induces aneuploidy via a nondisjunction event rather than chromosome lagging. Increases in chromosomal loss and breakage were observed using simultaneous FISH metaphase analysis of chromosomes 5, 7, 8, and 21, consistent with data obtained from the micronucleus and metaphase chromosome analyses. We conclude that TSA is both a clastogen and aneugen in the TK6 cell line and propose that the observed cytostatic and apoptotic properties of TSA may partially be due to this genotoxicity.Keywords
This publication has 19 references indexed in Scilit:
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTSAnnual Review of Pharmacology and Toxicology, 2005
- Trichostatin A-induced histone acetylation causes decondensation of interphase chromatinJournal of Cell Science, 2004
- Histone deacetylase inhibitors in cancer therapyCancer Cell, 2003
- Tumor cell‐specific cytotoxicity by targeting cell cycle checkpointsThe FASEB Journal, 2003
- Characteristics of γ-H2AX foci at DNA double-strand breaks sitesBiochemistry and Cell Biology, 2003
- Role of Histone Deacetylation in Developmentally Programmed DNA Rearrangements in Tetrahymena thermophilaEukaryotic Cell, 2002
- Identification of aneuploidy‐inducing agents using cytokinesis‐blocked human lymphocytes and an antikinetochore antibodyEnvironmental and Molecular Mutagenesis, 1989
- A simple technique for quantitation of low levels of DNA damage in individual cellsExperimental Cell Research, 1988
- Some heteroskedasticity-consistent covariance matrix estimators with improved finite sample propertiesJournal of Econometrics, 1985